This Amendment No. 2 supplements the information set forth in the Schedule 13D filed by the Reporting Persons with the United States Securities and Exchange Commission (the "SEC"), as amended from time to time (the "Schedule 13D"), relating to the Common Stock, par value $0.10 per share (the "Common Stock") of Unifi, Inc., a New York corporation (the "Issuer"). All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D.
The information set forth in response to each separate Item below shall be deemed to be a response to all Items where such information is relevant. The Schedule 13D is hereby supplementally amended as follows:
Item 3. Source and Amount of Funds or Other Consideration
The source of funds used for the purchase of the Issuer's securities was the working capital of ValueAct Spring Fund. The aggregate purchase price of the Common Stock is approximately $5,420,866.50.
Item 5. Interest in Securities of the Issuer
The responses to Items 3, 4 and 6 of this Schedule 13D are incorporated herein by reference.
(a) and (b). Set forth below is the beneficial ownership of shares of Common Stock of the Issuer for each person named in Item 2. Shares reported as beneficially owned by ValueAct Spring Fund are also reported as beneficially owned by (i) ValueAct Management L.P. as the manager of each such investment partnership, (ii) ValueAct Management LLC, as General Partner of ValueAct Management L.P., (iii) ValueAct Holdings, as the sole owner of the limited partnership interests of ValueAct Management L.P. and the membership interests of ValueAct Management LLC and as the majority owner of the membership interests of VA Partners I and (iv) ValueAct Holdings GP, as General Partner of ValueAct Holdings. Shares reported as beneficially owned by ValueAct Spring Fund are also reported as beneficially owned by VA Partners I, as General Partner of ValueAct Spring Fund. VA Partners I, ValueAct Management L.P., ValueAct Management LLC, ValueAct Holdings and ValueAct Holdings GP also, directly or indirectly, may own interests in one or more than one of the partnerships from time to time. Unless otherwise indicated below, by reason of such relationship ValueAct Spring Fund is reported as having shared power to vote or to direct the vote, and shared power to dispose or direct the disposition of, such shares of Common Stock, with VA Partners I (only with respect to ValueAct Spring Fund), ValueAct Management L.P., ValueAct Management LLC, ValueAct Holdings and ValueAct Holdings GP.
As of the date hereof, the Reporting Persons may be deemed to be the beneficial owner of 1,127,679 shares of Common Stock, representing approximately 6.1% of the Issuer's outstanding Common Stock. All percentages set forth in this Schedule 13D are based upon the Issuer's reported 18,382,797 outstanding shares of Common Stock as of November 1, 2018 as reported in the Issuer's Form 10-Q for the quarterly period ended September 30, 2018.
(c) The following table sets forth all transactions with respect to shares of Common Stock effected in the previous sixty days to this Schedule 13D by the Reporting Persons, inclusive of any transactions effected through 4:00 p.m., New York City time, on November 21, 2018. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission full information regarding the number of shares purchased in the below noted transactions at each separate price. Except as otherwise noted below, all such transactions were purchases or sales of shares of Common Stock effected in the open market.
Reporting Person: ValueAct Spring Fund
Trade Date | Buy/Sell | Shares Bought (Sold)
| Price Per Share
|
10/09/2018 | (1) | 610
| (1) |
11/06/2018 | Buy | 10,000 | $26.43 |
11/07/2018 | Buy | 7,100 | $26.36
|
11/08/2018 | Buy | 26,260 | $26.48 (2)
|
11/09/2018 | Buy | 5,216 | $26.48 |
11/12/2018 | Buy | 3,493 | $26.50 |
11/13/2018 | Buy | 19,200 | $26.95 |
11/14/2018 | Buy | 37,40 | $26.98 |
11/15/2018 | Buy | 11,300 | $26.92 |
11/16/2018 | Buy | 21,600 | $26.98 |
11/19/2018 | Buy | 8,000 | $26.92 |
11/20/2018 | Buy | 52,500 | $26.83 |
(1) Reflects the transfer to ValueAct Spring Fund of 610 shares, which were previously awarded to Ms. Zlotnicka on August 1, 2018 pursuant to the Issuer's Director compensation policy.
(2) Weighted-average price at which shares were purchased between the range of $26.48 and $26.50 per share.
(d) and (e) Not applicable.